Athira pharma to host educational webinar on targeting hgf/met: a naturally occurring neuronal repair pathway

Bothell, wash., april 08, 2021 (globe newswire) -- athira pharma, inc. (nasdaq: atha), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, today announced that it will host an educational webinar on targeting hgf/met, a naturally occurring, neuronal repair pathway. the live webinar event will be on thursday, april 15, at 1:30 p.m. pt / 4:30 p.m.et.
ATHA Ratings Summary
ATHA Quant Ranking